Evidence map›Paper›PMID 32050725›Full record

ReviewSensors (Basel, Switzerland)2020

Chiral Plasmonics and Their Potential for Point-of-Care Biosensing Applications.

Willian A Paiva-Marques, Faustino Reyes Gómez, Osvaldo N Oliveira, J Ricardo Mejía-Salazar

Abstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. AI-Based Metamaterial Design.ACS applied materials & interfaces · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Plasmonics for Telecommunications Applications.Sensors (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Willian A Paiva-MarquesNational Institute of Telecommunications (Inatel), Santa Rita do Sapucaí MG 37540-000, Brazil.
Faustino Reyes GómezSao Carlos Institute of Physics, University of Sao Paulo, PO Box 369, Sao Carlos, SP 13560-970, Brazil.
Osvaldo N OliveiraSao Carlos Institute of Physics, University of Sao Paulo, PO Box 369, Sao Carlos, SP 13560-970, Brazil.
J Ricardo Mejía-SalazarNational Institute of Telecommunications (Inatel), Santa Rita do Sapucaí MG 37540-000, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305958/2018-6; 429496/2018-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/14262-7Rede Nacional de Ensino e Pesquisa (RNP) 01250.075413/2018-04
6 · The paper itself

Abstract

There has been growing interest in using strong field enhancement and light localization in plasmonic nanostructures to control the polarization properties of light. Various experimental techniques are now used to fabricate twisted metallic nanoparticles and metasurfaces, where strongly enhanced chiral near-fields are used to intensify circular dichroism (CD) signals. In this review, state-of-the-art strategies to develop such chiral plasmonic nanoparticles and metasurfaces are summarized, with emphasis on the most recent trends for the design and development of functionalizable surfaces. The major objective is to perform enantiomer selection which is relevant in pharmaceutical applications and for biosensing. Enhanced sensing capabilities are key for the design and manufacture of lab-on-a-chip devices, commonly named point-of-care biosensing devices, which are promising for next-generation healthcare systems.

Indexed as

Biosensing TechniquesPoint-of-Care SystemsDNAElectricityGoldImaging, Three-DimensionalLipid BilayersNanostructuresNanotubesQuantum DotsStereoisomerismWaterDNAGoldLipid BilayersWaterbiosensingplasmonicstelecommunications

Identifiers

PMID32050725
PMCPMC7039232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.